Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Skin Neoplasms/immunology"'
Autor:
Robert J Harris, Zena Willsmore, Roman Laddach, Silvia Crescioli, Jitesh Chauhan, Anthony Cheung, Anna Black, Jenny L. C. Geh, Alastair D MacKenzie Ross, Ciaran Healy, Sophia Tsoka, James Spicer, Katie E Lacy, Sophia N Karagiannis
Publikováno v:
Harris, R J, Willsmore, Z, Laddach, R, Crescioli, S, Chauhan, J, Cheung, A, Black, A, Geh, J L C, MacKenzie Ross, A D, Healy, C, Tsoka, S, Spicer, J, Lacy, K E & Karagiannis, S N 2022, ' Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs ', OncoImmunology, vol. 11, no. 1, 2104426, pp. 2104426 . https://doi.org/10.1080/2162402X.2022.2104426
B cells are emerging as key players of anti-tumor adaptive immune responses. We investigated regulatory and pro-inflammatory cytokine-expressing B cells in patients with melanoma by flow cytometric intracellular cytokine, CyTOF, transcriptomic, immun
Autor:
Christian Posch, Veronica Aedo-Lopez, Julian Kofler, Julia Maria Ressler, Peter Koelblinger, Matthias Karasek, Christoph Hoeller, Christine Hafner, Helmut Kehrer, Olivier Michielin, Rita Silmbrod, Felix Weihsengruber, Erika Richtig, Lukas Koch, Sofiya Latifyan, Joanna Mangana
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Journal for immunotherapy of cancer, vol. 9, no. 2, pp. e001701
Journal for immunotherapy of cancer, vol. 9, no. 2, pp. e001701
BackgroundTalimogene laherparepvec (T-VEC) is a licensed therapy for use in melanoma patients of stage IIIB-IVM1a with injectable, unresectable metastatic lesions in Europe. Approval was based on the Oncovex Pivotal Trial in Melanoma study, which als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed27d867e0f6ae9e5fa254d7177dae2c
https://mediatum.ub.tum.de/1653382
https://mediatum.ub.tum.de/1653382
Autor:
Niels Ødum, Sergei B. Koralov, Bas G.J. Surewaard, Thorbjørn Krejsgaard, Terkild B. Buus, Lise M. Lindahl, Shamaila Munir Ahmad, Claudia Nastasi, Anders Woetmann, Lise Mette Rahbek Gjerdrum, Rachael A. Clark, Andreas Willerslev-Olsen, Lars Iversen, Tengpeng Hu, Simon Fredholm, Jürgen C. Becker, Mads Hald Andersen, Carsten Geisler, Edda Blümel, Hanne Fogh, Charlotte M. Bonefeld, Maria Gluud
Publikováno v:
Blümel, E, Munir Ahmad, S, Nastasi, C, Willerslev-Olsen, A, Gluud, M, Fredholm, S, Hu, T, Surewaard, B G J, Lindahl, L M, Fogh, H, Koralov, S B, Rahbek Gjerdrum, L M, Clark, R A, Iversen, L, Krejsgaard, T, Bonefeld, C M, Geisler, C, Becker, J C, Woetmann, A, Andersen, M H, Buus, T B & Ødum, N 2020, ' Staphylococcus aureus alpha-toxin inhibits CD8 + T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma ', OncoImmunology, vol. 9, no. 1, 1751561 . https://doi.org/10.1080/2162402X.2020.1751561
OncoImmunology, Vol 9, Iss 1 (2020)
Blümel, E, Munir Ahmad, S, Nastasi, C, Willerslev-Olsen, A, Gluud, M, Fredholm, S, Hu, T, Surewaard, B G J, Lindahl, L M, Fogh, H, Koralov, S B, Rahbek Gjerdrum, L M, Clark, R A, Iversen, L, Krejsgaard, T, Bonefeld, C M, Geisler, C, Becker, J C, Woetmann, A, Andersen, M H, Buus, T B & Ødum, N 2020, ' Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma ', OncoImmunology, vol. 9, no. 1, pp. 1751561 . https://doi.org/10.1080/2162402X.2020.1751561
Oncoimmunology
OncoImmunology, Vol 9, Iss 1 (2020)
Blümel, E, Munir Ahmad, S, Nastasi, C, Willerslev-Olsen, A, Gluud, M, Fredholm, S, Hu, T, Surewaard, B G J, Lindahl, L M, Fogh, H, Koralov, S B, Rahbek Gjerdrum, L M, Clark, R A, Iversen, L, Krejsgaard, T, Bonefeld, C M, Geisler, C, Becker, J C, Woetmann, A, Andersen, M H, Buus, T B & Ødum, N 2020, ' Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma ', OncoImmunology, vol. 9, no. 1, pp. 1751561 . https://doi.org/10.1080/2162402X.2020.1751561
Oncoimmunology
Staphylococcus aureus and its toxins have been linked to disease progression and mortality in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role in anti-cancer responses and high CD8+ T cell numbers in tumor lesions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c227141dd13596568b5954a415b5d59d
https://curis.ku.dk/ws/files/243011890/Staphylococcus_aureus_alpha_toxin_inhibits_CD8_T_cell_mediated_killing_of_cancer_cells_in_cutaneous_T_cell_lymphoma.pdf
https://curis.ku.dk/ws/files/243011890/Staphylococcus_aureus_alpha_toxin_inhibits_CD8_T_cell_mediated_killing_of_cancer_cells_in_cutaneous_T_cell_lymphoma.pdf
Autor:
Lars Ny, Elin M. V. Söderberg, Jonas Nilsson, Mattias F. Lindberg, Inge Marie Svane, Rikke Andersen, Henrik Jespersen, Lisa M. Nilsson, Marco Donia, Ulrich Keller
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Nature Communications
Jespersen, H, Lindberg, M F, Donia, M, Söderberg, E M V, Andersen, R, Keller, U, Ny, L, Svane, I M, Nilsson, L M & Nilsson, J A 2017, ' Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model ', Nature Communications, vol. 8, 707 . https://doi.org/10.1038/s41467-017-00786-z
Nature Communications
Jespersen, H, Lindberg, M F, Donia, M, Söderberg, E M V, Andersen, R, Keller, U, Ny, L, Svane, I M, Nilsson, L M & Nilsson, J A 2017, ' Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model ', Nature Communications, vol. 8, 707 . https://doi.org/10.1038/s41467-017-00786-z
Immune checkpoint inhibitors and adoptive cell transfer (ACT) of autologous tumor-infiltrating T cells have shown durable responses in patients with melanoma. To study ACT and immunotherapies in a humanized model, we have developed PDXv2.0 — a mela
Autor:
Nicolet, Benoît P, Guislain, Aurélie, van Alphen, Floris P J, Gomez-Eerland, Raquel, Schumacher, Ton N M, van den Biggelaar, Maartje, Wolkers, Monika C, Afd Pharmaceutics, Pharmaceutics
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 117(12), 6686. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America, 117(12), 6686-6696. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America, 117(12), 6686-6696. National Academy of Sciences
Cytotoxic CD8 + T cells can effectively kill target cells by producing cytokines, chemokines, and granzymes. Expression of these effector molecules is however highly divergent, and tools that identify and preselect CD8 + T cells with a cytotoxic expr
Autor:
Willeke A. M. Blokx, Stefania Di Blasio, I. Jolanda M. de Vries, J. Han van Krieken, Carl G. Figdor, Dagmar Verweij, Angela Vasaturo
Publikováno v:
Histopathology, 70, 4, pp. 643-649
Histopathology, 70, 643-649
Histopathology, 70(4), 643. Wiley-Blackwell
Histopathology, 70, 643-649
Histopathology, 70(4), 643. Wiley-Blackwell
Contains fulltext : 173035.pdf (Publisher’s version ) (Open Access) AIMS: The quality and quantity of the infiltration of immune cells into tumour tissues have substantial impacts on patients' clinical outcomes, and are associated with response to
Autor:
Daniel E. Speiser, Petra Baumgaertner, Mathilde Allard, Nathalie Rufer, Philippe O. Gannon, Sébastien Wieckowski, Michael Hebeisen
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 195(1)
Experimental models demonstrated that therapeutic induction of CD8 T cell responses may offer protection against tumors or infectious diseases providing that T cells have sufficiently high TCR/CD8:pMHC avidity for efficient Ag recognition and consequ
Autor:
Wolfram Sterry, Frank O. Nestle, Christiane Küenzlen, Wolf-Henning Boehncke, Natascha Potoczna, Günter Burg, Reinhard Dummer
Publikováno v:
Journal of Cutaneous Pathology, Vol. 23, No 4 (1996) pp. 298-305
Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of lymphoproliferative disorders. We investigated the variable region (V beta) of the T-cell receptor (TCR) repertoire in CTCL and compared it to the V beta repertoire in normal and eczemato
Autor:
Goldinger, SM, Dummer, R, Baumgaertner, P, Mihic-Probst, D, Schwarz, K, Hammann-Haenni, A, Willers, J, Geldhof, C, Prior, JO, Kündig, TM, Michielin, O, Bachmann, MF, Speiser, DE
Publikováno v:
European Journal of Immunology, vol. 42, no. 11, pp. 3049-3061
European Journal of Immunology
European Journal of Immunology
Optimal vaccine strategies must be identified for improving T-cell vaccination against infectious and malignant diseases. MelQbG10 is a virus-like nano-particle loaded with A-type CpG-oligonucleotides (CpG-ODN) and coupled to peptide(16-35) derived f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c2a961a5f3826a77e299439bc147982f
https://serval.unil.ch/notice/serval:BIB_FA34B494C8D3
https://serval.unil.ch/notice/serval:BIB_FA34B494C8D3
Autor:
Günther F.L. Hofbauer, Robert E. Hunger, Andreas L. Serra, Emmanuel Laffitte, Manuel Pascual, Francesco Pelloni, Alexandra Arnold, Isabelle Binet, Mark Anliker, Anne-Karine Lapointe, Werner Kempf
Publikováno v:
Swiss medical weekly, vol. 139, no. 29-30, pp. 407-415
Scopus-Elsevier
Günther Hofbauer
Swiss Medical Weekly, Vol. 139, No 29-30 (2009) pp. 407-15
Europe PubMed Central
Scopus-Elsevier
Günther Hofbauer
Swiss Medical Weekly, Vol. 139, No 29-30 (2009) pp. 407-15
Europe PubMed Central
Patients with a solid organ transplant have increased in numbers and in individual survival in Switzerland over the last decades. As a consequence of long-term immunosuppression, skin cancer in solid organ recipients (SOTRs) has been recognized as an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::553fbf14a6308eb4d1f5d02c8dcb5051
https://serval.unil.ch/notice/serval:BIB_00C4BE73949B
https://serval.unil.ch/notice/serval:BIB_00C4BE73949B